These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 16772121)

  • 41. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families.
    Bougeard G; Sesboüé R; Baert-Desurmont S; Vasseur S; Martin C; Tinat J; Brugières L; Chompret A; de Paillerets BB; Stoppa-Lyonnet D; Bonaïti-Pellié C; Frébourg T;
    J Med Genet; 2008 Aug; 45(8):535-8. PubMed ID: 18511570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Germline TP53 mutations and Li-Fraumeni syndrome.
    Varley JM
    Hum Mutat; 2003 Mar; 21(3):313-20. PubMed ID: 12619118
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Genetics and cancer of the breast].
    Sobol H; Bignon YJ; Eisinger F; Birnbaum D; Fervers B
    Ann Chir; 1994; 48(4):303-8. PubMed ID: 8085754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome.
    Wu CC; Shete S; Amos CI; Strong LC
    Cancer Res; 2006 Aug; 66(16):8287-92. PubMed ID: 16912210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [When is it useful to look for TP53 germline gene mutations in families of oncology patients?].
    Trková M; Sedlácek Z
    Cas Lek Cesk; 2003; 142(4):220-5. PubMed ID: 12841124
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chromosome instability in fibroblasts derived from Li-Fraumeni syndrome families without TP53 mutations.
    Boyle JM; Spreadborough A; Greaves MJ; Birch JM; Scott D
    Br J Cancer; 2000 Nov; 83(9):1136-8. PubMed ID: 11027425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Germline mutations of the p53 gene].
    Frebourg T
    Pathol Biol (Paris); 1997 Dec; 45(10):845-51. PubMed ID: 9769948
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation.
    Capponcelli S; Pedrini E; Cerone MA; Corti V; Fontanesi S; Alessio M; Bachi A; Soddu S; Ribatti D; Picci P; Helman LJ; Cantelli-Forti G; Sangiorgi L
    Hum Mutat; 2005 Aug; 26(2):94-103. PubMed ID: 15977174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myelodysplastic syndromes arising in patients with germline TP53 mutation and Li-Fraumeni syndrome.
    Talwalkar SS; Yin CC; Naeem RC; Hicks MJ; Strong LC; Abruzzo LV
    Arch Pathol Lab Med; 2010 Jul; 134(7):1010-5. PubMed ID: 20586629
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A rare tumor and an ethical dilemma in a family with a germline TP53 mutation.
    Prochazkova K; Foretova L; Sedlacek Z
    Cancer Genet Cytogenet; 2008 Jan; 180(1):65-9. PubMed ID: 18068537
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Li-Fraumeni syndrome and germ-line mutations of the p53 gene].
    Leblanc T; Soussi T
    Arch Pediatr; 1994 Jan; 1(1):61-70. PubMed ID: 8087224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database.
    Ognjanovic S; Olivier M; Bergemann TL; Hainaut P
    Cancer; 2012 Mar; 118(5):1387-96. PubMed ID: 21837677
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The relationship between radiation-induced G(1)arrest and chromosome aberrations in Li-Fraumeni fibroblasts with or without germline TP53 mutations.
    Boyle JM; Spreadborough A; Greaves MJ; Birch JM; Varley JM; Scott D
    Br J Cancer; 2001 Jul; 85(2):293-6. PubMed ID: 11461092
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased sperm aneuploidy in two male carriers of germline TP53 mutations.
    Paulasova P; Diblik J; Trkova M; Macek M; Sedlacek Z
    Cancer Genet; 2011 May; 204(5):278-81. PubMed ID: 21665182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Li-Fraumeni syndrome - a proposal of complex prevention care for carriers of TP53 mutation with total-body MRI].
    Foretová L; Stěrba J; Opletal P; Mach V; Lisý J; Petráková K; Palácová M; Navrátilová M; Gaillyová R; Puchmajerová A; Křepelová A; Macháčková E
    Klin Onkol; 2012; 25 Suppl():S49-54. PubMed ID: 22920207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relative frequency and morphology of cancers in carriers of germline TP53 mutations.
    Birch JM; Alston RD; McNally RJ; Evans DG; Kelsey AM; Harris M; Eden OB; Varley JM
    Oncogene; 2001 Aug; 20(34):4621-8. PubMed ID: 11498785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Homozygous disruption of PDZD7 by reciprocal translocation in a consanguineous family: a new member of the Usher syndrome protein interactome causing congenital hearing impairment.
    Schneider E; Märker T; Daser A; Frey-Mahn G; Beyer V; Farcas R; Schneider-Rätzke B; Kohlschmidt N; Grossmann B; Bauss K; Napiontek U; Keilmann A; Bartsch O; Zechner U; Wolfrum U; Haaf T
    Hum Mol Genet; 2009 Feb; 18(4):655-66. PubMed ID: 19028668
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family.
    Kappel S; Janschek E; Wolf B; Rudas M; Teleky B; Jakesz R; Kandioler D
    Breast Cancer Res Treat; 2015 Jun; 151(3):671-8. PubMed ID: 25981898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is there anticipation in the age at onset of cancer in families with Li-Fraumeni syndrome?
    Trkova M; Hladikova M; Kasal P; Goetz P; Sedlacek Z
    J Hum Genet; 2002; 47(8):381-6. PubMed ID: 12181637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome.
    Sugawara W; Arai Y; Kasai F; Fujiwara Y; Haruta M; Hosaka R; Nishida K; Kurosumi M; Kobayashi Y; Akagi K; Kaneko Y
    Genes Chromosomes Cancer; 2011 Jul; 50(7):535-45. PubMed ID: 21484931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.